COR.US Cencora Inc.

Healthcare Health Care Providers & Services USA Stocks
359.03 USD
Close of Nov 13, 2026
243.32 374.62
Market cap
USD 68.5B
P/E
19.5x
P/B
18.11x
ROE
94.6%
Dividend yield
0.76%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2026.

Is COR.US undervalued?

Graham number

The Graham number of Cencora Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cencora Inc. fundamental analysis

No fundamental analysis for Cencora Inc. yet.

Cencora Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cencora Inc.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and o…

Full company profile